🏆 Game 2 - Dycom $DY (-2,87 %)
vs. Standex $SXI (-1,21 %)

Scoring system as always:

• +1 point for clearly better value
• 0 points in case of a tie
• -1 point for clearly worse value

📊 1) Sales growth

2027:

• Dycom: 26,95 %
• Standex: 4,89 % ➡️ Point for Dycom

2028:

• Dycom: 9,77 %
• Standex: 9,05 % ➡️ Point for Dycom (close, but higher)

Intermediate score: Dycom +2

📈 2) Profit growth

2027:

• Dycom: -1,8 %
• Standex: 63,41 % ➡️ clear point for Standex

2028:

• Dycom: 42,82 %
• Standex: 40,98 % ➡️ narrow point for Dycom

Intermediate result: Dycom +2, Standex +1

💼 3) EBIT margin

2027:

• Dycom: 7,04 %
• Standex: 20,05 % ➡️ Point for Standex

2028:

• Dycom: 8,52 %
• Standex: 22,92 % ➡️ Point for Standex

Intermediate result: Dycom +2, Standex +3

🧠 4) ROE

2027:

• Dycom: 22,49 %
• Standex: 15,17 % ➡️ Point for Dycom

2028:

• Dycom: 24,89 %
• Standex: 16,26 % ➡️ Point for Dycom

💵 5) FCF Yield

2027:

• Dycom: 2,6 %
• Standex: 3,24 % ➡️ Point for Standex

2028:

• Dycom: 3,78 %
• Standex: 3,60 % ➡️ Point for Dycom

Intermediate result: Dycom +5, Standex +4

🏋️ 6) Debt-equity ratio

2027:

• Dycom: 1,75×
• Standex: 0,95× ➡️ clear point for Standex

2028:

• Dycom: 1,12×
• Standex: 0,85× ➡️ Point for Standex

Intermediate score: Dycom +5, Standex +6

💸 7) P/E RATIO

2027:

• Dycom: 45,1
• Standex: 27,9 ➡️ Point for Standex

2028:

• Dycom: 30,6
• Standex: 20,7 ➡️ Point for Standex

Intermediate score: Dycom +5, Standex +8

📉 8) PEG

2027:

• Dycom: -9,39 (negative → unusable)
• Standex: 0,4 ➡️ Point for Standex

2028:

• Dycom: 0,6
• Standex: 0,6 ➡️ 0 points (tie)

Final score: Dycom +5, Standex +9

🏁 Final result game 2

🏆 Standex wins game 2 with 9:5

🎙️Juan commentary on the game

"Dycom came into the game with brutal growth power, but Standex completely took them apart in the fundamentals."

• Dycom is faster, more aggressive, more volatile.
• Standex is more efficient, more profitable, more stable.

The turning point: The categories EBIT margin, P/E RATIO, PEG, Debt - Standex dominates here like a team that knows exactly how to win championships.

Dycom shines with ROE and salesbut loses too many "defense categories".

Juan's conclusion:

"Standex plays like a complete quality compounder. Dycom is spectacular, but Standex is superior."

CHAMPIONSHIP HEATMAP - GAME 2

Dycom vs. Standex - 2027 & 2028

🟢 = strong / advantage

🔴 = weak / disadvantage

🟡 = neutral

🎙️ Stadium commentary by Juan

"The points speak for themselves: Dycom sprints, Standex controls. In the championship heat map, you can immediately see who is the more complete team."

🎙️ Juan's commentary

"Standex leave the pitch as the new league leaders. Hexcel remains dangerous, but Standex has shown the cleaner profile."

🕒 COUNTDOWN - TOMORROW IS THE DUEL

T-1 day until the next big clash in our investor championship.

The tension is rising:

Dycom $DY (-2,87 %)
vs. Standex $SXI (-1,21 %)

The next round of the championship is coming up:

Dycomthe infrastructure specialist, meets Standexthe precise quality compounder.

Both teams bring their strongest "financial players" to the field: sales growth ⚡ profit power ⚡ margin stability ⚡ ROE ⚡ FCF power ⚡ leverage ⚡ valuation

"Only those who excel in all disciplines will make it one round further."

Get ready for an intense duel in the Investors' Stadium.

Both teams are ready. Both teams know what's at stake. Only one will advance.

"Tomorrow will decide who dominates the field."

The countdown is on.

PS. Today's match is still ongoing. We will announce the result here in the late afternoon.

Good morning my dears,

Juan was in the USA before his trip to Asia and will be returning there tomorrow.

My dears, now fasten your seatbelts. Juan is planning something very special and unprecedented for you.

" 🏆The great championship of industrial values "

Companies that I have already presented and companies that we will present to you next week will take part here.

The exact course of the championship and the participating teams (companies) will be explained and presented in a separate post.

Today I would like to introduce you to one of the companies that Juan visited before his trip to Asia and which qualified.

As always, I look forward to your comments on the company.

And perhaps a small fan club will form today.

Standex International $SXI (-1,21 %)

The Standex International Corporation is a global multi-industry manufacturer. Its segments include Electronics, Engraving, Scientific, Engineering Technologies and Specialty Solutions. The Electronics segment manufactures and distributes electronic components for applications across the spectrum of the consumer market. The Engraving segment offers mold texturing, slush molding tools and project management and design services. The Scientific segment sells temperature-controlled specialty equipment for the medical, scientific, pharmaceutical, biotechnology and industrial markets. The Engineering Technologies segment offers customized solutions from a single source for the manufacture of technical components for the aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space sectors. The Specialty Solutions segment produces and distributes refrigerated, heated and dry display cases as well as single and double-acting telescopes.

Number of employees: 4,100

Präsentation herunterladen

Breakdown of sales by business division:

2025 (USD)

Electronics 400 million

Engraving 128 million

Engineering Technologies 103 million

Specialty Solutions 86.64 million

Scientific 72.38 million

Geographical distribution of sales:

2025 (USD)

USA 467 million

Asia Pacific 194 million

Europe, Middle East S. Africa 9.12 million

🤖 Juan's conclusion on Standex (2025-2028)

Standex delivers a clean, predictable growth profile: Sales increase steadily every year, with a clear boost in 2026 and again in 2028. EBIT grows disproportionately, which shows that the operating leverage is working.

Profitability improves structurally: EBIT margin picks up significantly from 2027, indicating pricing power and mix effects. EBITDA margin remains consistently strong.

Free cash flow remains the only shaky point: 2025 and 2028 lack forecasts, but 2026/27 show solid double-digit FCF margins. No alarm, but a point to follow up.

Debt is clearly developing positively: Leverage falls from 2.63× (2025) to 0.95× (2027). This is a massive de-risking effect and increases the valuation range upwards.

EPS momentum is the star of the table: 2025 weak, but earnings growth explodes thereafter. 2027/28 deliver real momentum - typical for companies entering a new margin phase.

ROE is low but stable: 2025 not a high-flyer at 8.48%, but combined with falling debt and rising margins, this suggests ROE expansion ahead.

🎯 Juan's overall assessment

Standex looks like a classic under-the-radar compounder: solid sales growth, rising margins, falling debt, strong EPS momentum. If the FCF data is positively trailed in 2028, this could trigger a valuation re-rating.

Market value 3,312

Number of shares (in thousands) 12,119

Date of publication 31,07,2025

🤖 Juan conclusion - Standex valuation ratios (2025-2028)

Standex looks like a company that is just entering a revaluation phase. The P/E ratio is falling cleanly from 33× to 20× over the years, while EPS is growing strongly at the same time. This is the kind of divergence that the market eventually stops ignoring.

The FCF yield is not yet a buy argument, but it is a trend argument. 2026 and 2027 are only at 2.9-3.2%. This is low, but typical for companies that are just entering a higher margin phase. If a positive FCF comes in 2028, the picture will immediately tilt towards "quality compounders".

PEG is the most exciting indicator in the entire block. 2027 with 0.4× is a classic "Growth at a Reasonable Price" signal. 2028 with 0.6× confirmed: Growth is real, not expensive, and is not yet fully priced in by the market.

Dividend? Doesn't matter here. Standex is a reinvestor, not a distributor. This is even an advantage for growth phases.

P/B ratio is missing - but that is not a problem. For asset-light companies, the P/B ratio is hardly meaningful anyway. The story is about margins, cash flow and EPS.

🎯 Juan's overall assessment

Standex looks like a stock that is improving fundamentally, while at the same time the valuation is getting cheaper. This is the kind of setup that often leads to a silent but very stable re-rating.

If the FCF data turns positive in 2028, Standex could be transformed from a "solid industrial stock" into a genuine quality compounder quality compounder.

PRICE € 233.00 (26.04.2026 at 10:00 a.m.)

$SXI (-1,21 %)